United Arab Emirates Lung Cancer Diagnostics Market to 2032
Overview
The United Arab Emirates Lung Cancer Diagnostics Market is expected to reach a 30.41 USD Billion by 2032 and is projected to grow at a CAGR of 12.01% from 2025 to 2032.
Revenue, 2024 (USD Billion)
15.42
Forecast, 2032 (USD Billion)
30.41
CAGR, 2024 - 2032
12.01%
Report Coverage
United Arab Emirates
United Arab Emirates Lung Cancer Diagnostics Market 2018-2032 USD Billion
United Arab Emirates Lung Cancer Diagnostics Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 15.42 USD Billion
- Projected Market Size (2032): 30.41 USD Billion
- CAGR (2025-2032): 12.01%
Key Findings of United Arab Emirates Lung Cancer Diagnostics Market
- The United Arab Emirates Lung Cancer Diagnostics Market was valued at 15.42 USD Billion in 2024.
- The United Arab Emirates Lung Cancer Diagnostics Market is likely to grow at a CAGR of 12.01% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Non-Small Cell Lung Cancer in Cancer Segment accounted for the largest share of the market with a revenue of 12.47 USD Billion
- The fastest growing segment Hospital in End User Segment grew Fastest with a CAGR of 13.38% during the forecast period from 2024 to 2032.
United Arab Emirates Lung Cancer Diagnostics Market Scope
United Arab Emirates Lung Cancer Diagnostics Market Segmentation & Scope
Distribution Channel
- Retail Sales
- Direct Tender
End User
- Others
- Cancer Research Institutes
- Diagnostic Imaging Centers
- Independent Diagnostic Laboratories
- Associated Labs
- Hospital
Cancer
- Small Cell Lung Cancer
- Non-Small Cell Lung Cancer
Test
- Others
- Blood Test
- Biopsy
- Biomarkers Test
- Imaging Test
Product
- Consumables & Accessories
- Instruments
United Arab Emirates Lung Cancer Diagnostics Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 15.42 USD Billion |
| Market Value in 2032 | 30.41 USD Billion |
| CAGR (2025-2032) | 12.01% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Distribution Channel,End User,Cancer,Test,Product |
Regional Insights:
-
Leading Market (2024-2032): United Arab Emirates, leading in terms of revenue 15.42 USD Billion in 2024
- Key Country: United Arab Emirates, leading in terms of revenue with value of 15.42 USD Billion in 2024.
Segments and Scope
-
United Arab Emirates Lung Cancer Diagnostics Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in United Arab Emirates Lung Cancer Diagnostics Market to 2032 with a revenue of 9.77 USD Billion in the year 2024.
- Direct Tender is the Fastest growing segment in United Arab Emirates Lung Cancer Diagnostics Market to 2032 with a Growth rate of 12.91 % in forecast period 2025-2032.
-
United Arab Emirates Lung Cancer Diagnostics Market to 2032, By End User
- Hospital is the largest segment in United Arab Emirates Lung Cancer Diagnostics Market to 2032 with a revenue of 6.02 USD Billion in the year 2024.
- Hospital is the Fastest growing segment in United Arab Emirates Lung Cancer Diagnostics Market to 2032 with a Growth rate of 13.38 % in forecast period 2025-2032.
-
United Arab Emirates Lung Cancer Diagnostics Market to 2032, By Cancer
- Non-Small Cell Lung Cancer is the largest segment in United Arab Emirates Lung Cancer Diagnostics Market to 2032 with a revenue of 12.47 USD Billion in the year 2024.
- Non-Small Cell Lung Cancer is the Fastest growing segment in United Arab Emirates Lung Cancer Diagnostics Market to 2032 with a Growth rate of 12.19 % in forecast period 2025-2032.
-
United Arab Emirates Lung Cancer Diagnostics Market to 2032, By Test
- Imaging Test is the largest segment in United Arab Emirates Lung Cancer Diagnostics Market to 2032 with a revenue of 8.93 USD Billion in the year 2024.
- Imaging Test is the Fastest growing segment in United Arab Emirates Lung Cancer Diagnostics Market to 2032 with a Growth rate of 12.78 % in forecast period 2025-2032.
-
United Arab Emirates Lung Cancer Diagnostics Market to 2032, By Product
- Instruments is the largest segment in United Arab Emirates Lung Cancer Diagnostics Market to 2032 with a revenue of 10.78 USD Billion in the year 2024.
- Instruments is the Fastest growing segment in United Arab Emirates Lung Cancer Diagnostics Market to 2032 with a Growth rate of 12.68 % in forecast period 2025-2032.
United Arab Emirates Lung Cancer Diagnostics Market Company Share Analysis
| Company Name |
|
||
| Thermo Fisher Scientific Inc. | |||
| Quest Diagnostics Incorporated | |||
| Bio-Rad Laboratories, Inc. | |||
| Abbott | |||
| Guardant Health | |||
United Arab Emirates Lung Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Billion
United Arab Emirates Lung Cancer Diagnostics Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The United Arab Emirates Lung Cancer Diagnostics Market is segmented based on Segmentation Distribution Channel,End User,Cancer,Test,Product.
United Arab Emirates Lung Cancer Diagnostics Market was valued at USD 15.42(Revenue in USD Billion) in 2021.
United Arab Emirates Lung Cancer Diagnostics Market is projected to grow at a CAGR of 12.01% during the forecast period of 2024 to 2032.
The Non-Small Cell Lung Cancer segment is expected to dominate the United Arab Emirates Lung Cancer Diagnostics Market, holding a largest market share of 12.47 USD Billion in 2024
United Arab Emirates Lung Cancer Diagnostics Market Scope
United Arab Emirates Lung Cancer Diagnostics Market Segmentation & Scope
Distribution Channel
- Retail Sales
- Direct Tender
End User
- Others
- Cancer Research Institutes
- Diagnostic Imaging Centers
- Independent Diagnostic Laboratories
- Associated Labs
- Hospital
Cancer
- Small Cell Lung Cancer
- Non-Small Cell Lung Cancer
Test
- Others
- Blood Test
- Biopsy
- Biomarkers Test
- Imaging Test
Product
- Consumables & Accessories
- Instruments
Frequently Asked Questions
The United Arab Emirates Lung Cancer Diagnostics Market is segmented based on Segmentation Distribution Channel,End User,Cancer,Test,Product.
United Arab Emirates Lung Cancer Diagnostics Market was valued at USD 15.42(Revenue in USD Billion) in 2021.
United Arab Emirates Lung Cancer Diagnostics Market is projected to grow at a CAGR of 12.01% during the forecast period of 2024 to 2032.
The estimated market value of the United Arab Emirates Lung Cancer Diagnostics Market for final year is USD 30.41 (USD Billion).
United Arab Emirates Lung Cancer Diagnostics Market Company Profiling
Frequently Asked Questions
The United Arab Emirates Lung Cancer Diagnostics Market is segmented based on Segmentation Distribution Channel,End User,Cancer,Test,Product.
United Arab Emirates Lung Cancer Diagnostics Market was valued at USD 15.42(Revenue in USD Billion) in 2021.
United Arab Emirates Lung Cancer Diagnostics Market is projected to grow at a CAGR of 12.01% during the forecast period of 2024 to 2032.
The estimated market value of the United Arab Emirates Lung Cancer Diagnostics Market for final year is USD 30.41 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.